International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage, health and biosciences, scent and pharma solutions, and complementary adjacent products. The Company operates through four segments. The Nourish segment consists of a portfolio of natural-based ingredients to enhance nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications and consists of ingredients, flavors and food designs.
The Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. The Scent segment creates fragrance compounds and fragrance ingredients. The Pharma Solutions segment produces a portfolio that includes cellulosics and seaweed-based pharmaceutical excipients, used to improve the functionality and delivery of active pharmaceutical ingredients..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 984.8K |
Three Month Average Volume | 27.8M |
High Low | |
Fifty-Two Week High | 104.17 USD |
Fifty-Two Week Low | 62.28 USD |
Fifty-Two Week High Date | 30 Aug 2024 |
Fifty-Two Week Low Date | 06 Oct 2023 |
Price and Volume | |
Current Price | 103.99 USD |
Beta | 1 |
Relative Price Change | |
Four Week Relative Price Change | 2.39% |
Thirteen Week Relative Price Change | 1.02% |
Twenty-Six Week Relative Price Change | 24.64% |
Fifty-Two Week Relative Price Change | 17.80% |
Year-to-Date Relative Price Change | 8.45% |
Price Change | |
One Day Price Change | 1.03% |
Thirteen Week Price Change | 8.12% |
Twenty-Six Week Price Change | 37.05% |
Five Day Price Change | 3.91% |
Fifty-Two Week Price Change | 47.61% |
Year-to-Date Price Change | 28.43% |
Month-to-Date Price Change | 4.53% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 57.23328 USD |
Book Value Per Share (Most Recent Quarter) | 55.75439 USD |
Tangible Book Value Per Share (Last Fiscal Year) | -17.16097 USD |
Tangible Book Value Per Share (Most Recent Quarter) | -7.46704 USD |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 8.95797 USD |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 45.01569 USD |
Revenue Per Share (Trailing Twelve Months) | 44.22678 USD |
Dividend | |
Dividend Per Share (Last Fiscal Year) | 3.24 USD |
Dividend Per Share (Trailing Twelve Months) | 2.42 USD |
Dividend Per Share (5 Year) | 3.112 USD |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | -10.05882 USD |
Excluding Extraordinary Items (Trailing Twelve Months) | -9.22743 USD |
Normalized (Last Fiscal Year) | -2.12373 USD |
Basic Excluding Extraordinary Items (Last Fiscal Year) | -10.05882 USD |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | -9.22353 USD |
Including Extraordinary Items (Last Fiscal Year) | -10.05882 USD |
Including Extraordinary Items (Trailing Twelve Months) | -9.22743 USD |
Cash | |
Cash Per Share (Last Fiscal Year) | 2.75375 USD |
Cash Per Share (Most Recent Quarter) | 2.62461 USD |
Cash Flow Per Share (Last Fiscal Year) | -5.57255 USD |
Cash Flow Per Share (Trailing Twelve Months) | -4.87195 USD |
Free Cash Flow Per Share (Trailing Twelve Months) | 1.03617 USD |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | 0 |
Cash Flow Revenue (Trailing Twelve Months) | 2 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | -20.19% |
Pretax Margin (Last Fiscal Year) | -21.94% |
Pretax Margin (5 Year) | -6.09% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 32.07% |
Gross Margin (Trailing Twelve Months) | 34.27% |
Gross Margin (5 Year) | 34.42% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | -18.39% |
Operating Margin (Trailing Twelve Months) | -14.39% |
Operating Margin (5 Year) | -3.54% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | -22.33% |
Net Profit Margin (Trailing Twelve Months) | -20.77% |
Net Profit Margin (5 Year) | -7.25% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | 0.23% |
Tangible Book Value (5 Year) | -99,999.99% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | 26.52% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | -1.37% |
Revenue Growth (3 Year) | 23.61% |
Revenue Change (Trailing Twelve Months) | -4.65% |
Revenue Per Share Growth | -0.05% |
Revenue Growth (5 Year) | 31.19% |
Capital Spending Debt | |
Capital Spending (5 Year) | 23.74% |
Total Debt (5 Year) | 17.25% |
Dividends | |
Dividend Growth (3 Year) | 2.15% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 551.29% |
EPS Change (Trailing Twelve Months) | -6.76% |
EPS Growth (3 Year) | -99,999.99% |
EPS Growth (5 Year) | -99,999.99% |
EBITDA | |
EBITDA (5 Year) | 23.00% |
EBITDA (5 Year Interim) | 19.59% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -99,999.99% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | -100,000 |
Price to Tangible Book (Most Recent Quarter) | -100,000 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | 242 |
Price to Free Cash Per Share (Trailing Twelve Months) | 100 |
Net Debt | |
Net Debt (Most Recent Quarter) | 8.7B |
Net Debt (Last Fiscal Year) | 9.4B |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 2 |
Price to Sales (Trailing Twelve Months) | 2 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
PE Normalized (Last Fiscal Year) | -100,000 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 1.0K |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 24 |
PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
Dividends | |
Dividend Yield (5 Year) | 2.71% |
Dividend Yield | 1.54% |
Current Dividend Yield | 2.33% |
Price to Book | |
Price to Book (Last Fiscal Year) | 2 |
Price to Book (Most Recent Quarter) | 2 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 63 |
Long Term Debt to Equity (Most Recent Quarter) | 60 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | -99,999.99% |
Payout Ratio (Trailing Twelve Months) | -99,999.99% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 1 |
Quick Ratio (Most Recent Quarter) | 2 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 2 |
Current Ratio (Most Recent Quarter) | 2 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | 110.0M |
Free Cash Flow (Trailing Twelve Months) | 265.0M |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | 2 |
Net Interest Coverage (Trailing Twelve Months) | 4 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 69 |
Total Debt to Equity (Most Recent Quarter) | 66 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | -7.71% |
Return on Assets (Trailing Twelve Months) | -7.34% |
Return on Assets (5 Year) | -2.68% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | -15.90% |
Return on Equity (Trailing Twelve Months) | -14.76% |
Return on Equity (5 Year) | -5.44% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | -8.70% |
Return on Investment (Trailing Twelve Months) | -8.31% |
Return on Investment (5 Year) | -3.01% |